By Maya Rajamani ( May 12, 2015, 7:34 PM EDT) -- American health care company Baxter International Inc. will pay Italian company Sigma-Tau Finanziaria S.p.A. $900 million for blockbuster leukemia treatment Oncaspar and at least one other cancer drug still in development, and spin off the holding into a publicly traded subsidiary, the company said Tuesday....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.